Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,861 to 1,880 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course. | Sci Rep | 2020 | 32483203 | PubTator, text mining | PubMed |
| Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain. | Front Psychiatry | 2020 | 32477182 | PubTator, text mining | PubMed |
| Thromboembolic Risk of C1 Esterase Inhibitors: A Systematic Review on Current Evidence. | Expert Rev Clin Pharmacol | 2020 | 32476505 | PubTator, text mining | PubMed |
| Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage. | Front Immunol | 2020 | 32457738 | PubTator, text mining | PubMed |
| An outlook on biomarkers in cardiogenic shock. | Curr Opin Crit Care | 2020 | 32452847 | PubTator, text mining | PubMed |
| Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. | Allergy | 2020 | 32452549 | PubTator, text mining | PubMed |
| RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. | Sci Rep | 2020 | 32451443 | PubTator, text mining | PubMed |
| Novel homozygous variants in the SERPING1 gene in two Turkish families with hereditary angioedema of recessive inheritance. | Immunol Cell Biol | 2020 | 32445210 | PubTator, text mining | PubMed |
| High prevalence of epilepsy in HAE with normal C1-INH. | Allergol Int | 2020 | 32444305 | PubTator, text mining | PubMed |
| Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients. | Front Immunol | 2020 | 32431708 | PubTator, text mining | PubMed |
| Self-Management Plans in Patients with Hereditary Angioedema: Strategies, Outcomes and Integration into Clinical Care. | J Asthma Allergy | 2020 | 32431520 | PubTator, text mining | PubMed |
| MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides. | Front Immunol | 2020 | 32425936 | PubTator, text mining | PubMed |
| The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications. | Expert Rev Proteomics | 2020 | 32425074 | PubTator, text mining | PubMed |
| Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis. | Sci Rep | 2020 | 32424199 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay Between Innate and Adaptive Immune Dysfunction. | Int J Mol Sci | 2020 | 32408613 | PubTator, text mining | PubMed |
| Pharmacokinetics, Pharmacodynamics, and Exposure-Response of Lanadelumab for Hereditary Angioedema. | Clin Transl Sci | 2020 | 32407574 | PubTator, text mining | PubMed |
| Identification of the minimum region of Bordetella pertussis Vag8 required for interaction with C1 inhibitor. | Microbiol Immunol | 2020 | 32396237 | PubTator, text mining | PubMed |
| Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study. | Biosci Rep | 2020 | 32391563 | PubTator, text mining | PubMed |
| Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways. | Sci Rep | 2020 | 32385381 | PubTator, text mining | PubMed |
| Idiopathic Angioedema: Current Challenges. | J Asthma Allergy | 2020 | 32368100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=94